Lbmc Investment Advisors, LLC Pfizer Inc Transaction History

Lbmc Investment Advisors, LLC

$1.26 Billion
Q3 2024

A detailed history of Lbmc Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lbmc Investment Advisors, LLC holds 13,858 shares of PFE stock, worth $365,296. This represents 0.03% of its overall portfolio holdings.

Number of Shares

13,858

Previous 13,858 -0.0%

Holding current value

$365,296

Previous $387,000 3.62%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$25.26 - $29.6 $37,763 - $44,252	-1,495 Reduced 9.74%	13,858 $387,000
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $33,760 - $38,767	-1,304 Reduced 7.83%	15,353 $426,000
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $6,166 - $8,009	-236 Reduced 1.4%	16,657 $479,000
Q3 2023 Oct 05, 2023	SELL	$32.09 - $37.51 $160 - $187	-5 Reduced 0.03%	16,893 $560,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $4,659 - $5,390	-129 Reduced 0.76%	16,898 $619,000
Q1 2023 Apr 10, 2023	BUY	$39.39 - $51.28 $346,513 - $451,110	8,797 Added 106.89%	17,027 $694,000
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $30,185 - $39,403	-723 Reduced 8.08%	8,230 $0
Q2 2022 Jul 07, 2022	BUY	$46.53 - $55.17 $46,530 - $55,170	1,000 Added 12.57%	8,953 $469,000
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $2,653 - $3,288	-58 Reduced 0.72%	7,953 $412,000
Q4 2021 Mar 17, 2022	BUY	$41.32 - $61.25 $242,878 - $360,027	5,878 Added 275.57%	8,011 $473,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $229,926 - $295,360	-5,858 Reduced 73.31%	2,133 $344,000
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $286,956 - $325,073	7,991 New	7,991 $313,000
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $195,849 - $220,878	-5,848 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$33.47 - $42.56 $195,732 - $248,890	5,848 New	5,848 $215,000
Q2 2020 Jul 14, 2020	SELL	$30.12 - $36.54 $186,503 - $226,255	-6,192 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $3,851 - $4,371	117 Added 1.93%	6,192 $243,000
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $31,027 - $40,234	-955 Reduced 13.58%	6,075 $218,000
Q2 2019 Jul 18, 2019	BUY	$36.98 - $41.52 $23,112 - $25,950	625 Added 9.76%	7,030 $305,000
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $56,925 - $62,541	-1,518 Reduced 19.16%	6,405 $272,000
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $22,581 - $25,745	-587 Reduced 6.9%	7,923 $346,000
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $13,960 - $16,933	-405 Reduced 4.54%	8,510 $375,000
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $24,339 - $25,948	738 Added 9.03%	8,915 $323,000
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $20,230 - $23,470	-634 Reduced 7.2%	8,177 $290,000
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $293,053 - $310,940	8,811	8,811 $319,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lbmc Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lbmc Investment Advisors, LLC with notifications on news.

Account

Lbmc Investment Advisors, LLC Pfizer Inc Transaction History